| Z-VAD-FMKCell-permeable, irreversible pan-caspase inhibitor |
Sample solution is provided at 25 µL, 10mM.
- 1.Yosef R, Pilpel N, et al. "p21 maintains senescent cell viability under persistent DNA damage response by restraining JNK and caspase signaling." EMBO J. 2017 Jun 12. pii: e201695553. PMID:28607003
- 2.Ma Y, Walsh MJ, et al. "CRISPR/Cas9 Screens Reveal Epstein-Barr Virus-Transformed B Cell Host Dependency Factors." Cell Host Microbe. 2017 May 10;21(5):580-591.e7. PMID:28494239
- 3.Jaco I, Annibaldi A, et al. "MK2 Phosphorylates RIPK1 to Prevent TNF-Induced Cell Death." Mol Cell. 2017 Jun 1;66(5):698-710.e5. PMID:28506461
- 4.Boyd-Tressler AM, Lane GS, et al. "Up-regulated Ectonucleotidases in Fas-Associated Death Domain Protein- and Receptor-Interacting Protein Kinase 1-Deficient Jurkat Leukemia Cells Counteract Extracellular ATP/AMP Accumulation via Pannexin-1 Channels during Chemotherapeutic Drug-Induced Apoptosis." Mol Pharmacol. 2017 Jul;92(1):30-47. PMID:28461585
- 5.Saleh D, Najjar M, et al. "Kinase Activities of RIPK1 and RIPK3 Can Direct IFN-β Synthesis Induced by Lipopolysaccharide." J Immunol. 2017 Jun 1;198(11):4435-4447. PMID:28461567
- 6.Gong YN, Guy C, et al. "ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences." Cell. 2017 Apr 6;169(2):286-300.e16. PMID:28388412
- 7.Chirieleison SM, Marsh RA, et al. "Nucleotide-binding oligomerization domain (NOD) signaling defects and cell death susceptibility cannot be uncoupled in X-linked inhibitor of apoptosis (XIAP)-driven inflammatory disease." J Biol Chem. 2017 Apr 12. pii: jbc.M117.781500. PMID:28404814
- 8.Ardeshir Ariana,Faculty of Medicine, et al, "Dissection of TLR4-induced necroptosis using specific inhibitors of endocytosis and p38 MAPK." University of Ottawa. 2017.
- 9.Agabiti SS, Li J, et al. "Geranylgeranyl diphosphate synthase inhibition induces apoptosis that is dependent upon GGPP depletion, ERK phosphorylation and caspase activation." Cell Death Dis. 2017 Mar 16;8(3):e2678. PMID:28300835
- 10. Faculty of Medicine University of Ottawa,et al. "FoxO3a signaling promotes the inflammatory response during Salmonella Typhimurium infection."University of Ottawa, 2017.
- 11.Iurlaro R, Püschel F, et al. "Glucose Deprivation Induces ATF4-Mediated Apoptosis through TRAIL Death Receptors." Mol Cell Biol. 2017 May 2;37(10). pii: e00479-16. PMID:28242652
- 12.Cirka HA, Uribe J, et al. "Reproducible in vitro model for dystrophic calcification of cardiac valvular interstitial cells: insights into the mechanisms of calcific aortic valvular disease." Lab Chip. 2017 Feb 28;17(5):814-829. PMID:28128382
- 13.Rogers C, Fernandes-Alnemri T, et al. "Cleavage of DFNA5 by caspase-3 during apoptosis mediates progression to secondary necrotic/pyroptotic cell death." Nat Commun. 2017 Jan 3;8:14128. PMID:28045099
- 14.Gong YN, Guy C, et al. "ESCRT-III Acts Downstream of MLKL to Regulate Necroptotic Cell Death and Its Consequences." Cell. 2017 Apr 6;169(2):286-300.e16. PMID:28388412
- 15.Gelles JD, Edward Chipuk J. "Robust high-throughput kinetic analysis of apoptosis with real-time high-content live-cell imaging. Cell Death Dis." 2016 Dec 1;7(12):e2493. PMID:27906190
- 16.Vylkova S, Lorenz MC. "Phagosomal Neutralization by the Fungal Pathogen Candida albicans Induces Macrophage Pyroptosis." Infect Immun. 2017 Jan 26;85(2). pii: e00832-16. PMID:27872238
- 17.Li J, Falcone ER, et al. "Novel α-substituted tropolones promote potent and selective caspase-dependent leukemia cell apoptosis." Pharmacol Res. 2016 Sep 20;113(Pt A):438-448. PMID:27663262
- 18.Li Y, Li A, et al. "MiR-182-5p protects inner ear hair cells from cisplatin-induced apoptosis by inhibiting FOXO3a." Cell Death Dis. 2016 Sep 8;7(9):e2362. PMID:27607577
- 19.Karunakaran D, Geoffrion M, et al. "Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis." Sci Adv. 2016 Jul 22;2(7):e1600224. PMID:27532042
- 20.Shi XJ, Yu B, et al. "Structurally novel steroidal spirooxindole by241 potently inhibits tumor growth mainly through ROS-mediated mechanisms." Sci Rep. 2016 Aug 16;6:31607. PMID:27527552
- 21.Russo HM, Rathkey J, et al. "Active Caspase-1 Induces Plasma Membrane Pores That Precede Pyroptotic Lysis and Are Blocked by Lanthanides." J Immunol. 2016 Aug 15;197(4):1353-67. PMID:27385778
- 22.Kang, Seokwon, et al. "Caspase-8 scaffolding function and MLKL regulate NLRP3 inflammasome activation downstream of TLR3." Nature communications 6 (2015). PMID:26104484
- 23.Abrams, Michael J., et al. "Self-repairing symmetry in jellyfish through mechanically driven reorganization." Proceedings of the National Academy of Sciences (2015): 201502497. PMID:26080418
- 24.Karmakar M, Katsnelson M, et al. "Neutrophil IL-1β processing induced by pneumolysin is mediated by the NLRP3/ASC inflammasome and caspase-1 activation and is dependent on K+ efflux." J Immunol. 2015 Feb 15;194(4):1763-75. PMID:25609842
- 25.Fiesel, Fabienne C, et al. "(Patho‐) physiological relevance of PINK1‐dependent ubiquitin phosphorylation." EMBO reports (2015): e201540514. PMID:26162776
- 26.Rodriguez, D. A., et al. "Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis." Cell Death & Differentiation (2015). PMID:26024392
- 27.Karmakar, Mausita, et al. "Neutrophil IL-1β Processing Induced by Pneumolysin Is Mediated by the NLRP3/ASC Inflammasome and Caspase-1 Activation and Is Dependent on K+ Efflux." The Journal of Immunology (2015): 1401624. PMID:25609842
- 28.Shah A, Vaidya NK, et al. "HIV-1 gp120 induces type-1 programmed cell death through ER stress employing IRE1α, JNK and AP-1 pathway." Sci Rep. 2016 Jan 7;6:18929. PMID:26740125
- 29.Zhao XM, Chen Z, et al. "Hsp90 modulates the stability of MLKL and is required for TNF-induced necroptosis." Cell Death Dis. 2016 Feb 11;7:e2089. PMID:26866270
- 30. Yalon M, Tuval-Kochen L, et al. "Overcoming Resistance of Cancer Cells to PARP-1 Inhibitors with Three Different Drug Combinations." PLoS One. 2016 May 19;11(5):e0155711. PMID:27196668
- 31.Hsieh Y Y, Chou C J, Lo H L, et al. "Repositioning of a cyclin-dependent kinase inhibitor GW8510 as a ribonucleotide reductase M2 inhibitor to treat human colorectal cancer[J]." Cell Death Discovery, 2016, 2.
- 32.Lu, Kang, et al. "The STAT3 inhibitor WP1066 reverses the resistance of chronic lymphocytic leukemia cells to histone deacetylase inhibitors induced by interleukin-6." Cancer Letters (2015). PMID:25636517
- 33.Rayavarapu R R, Heiden B, Pagani N, et al. "The Role of Multicellular Aggregation in the Survival of ErbB2-Positive Breast Cancer Cells during Extracellular Matrix-Detachment[J]". Journal of Biological Chemistry, 2015: jbc. M114. 612754. PMID:25681438
- 34.Xiong, J., et al. "Dysregulated choline metabolism in T-cell lymphoma: role of choline kinase-α and therapeutic targeting." Blood cancer journal 5.3 (2015): 287. PMID:25768400
- 35.Antonopoulos, Christina, et al. "Caspase-8 as an Effector and Regulator of NLRP3 Inflammasome Signaling." Journal of Biological Chemistry (2015): jbc-M115. PMID:26100631
- 36.Hiller, Bradley E., Angela K. Berger, and Pranav Danthi. "Viral gene expression potentiates reovirus-induced necrosis." Virology 484 (2015): 386-394. PMID:26226583
- 37.Tian, Chongchong, et al. "A novel dual EGFR/HER2 inhibitor KU004 induces cell cycle arrest and apoptosis in HER2-overexpressing cancer cells." Apoptosis 20.12 (2015): 1599-1612. PMID:26437915
- 38.Harris, Katharine G., and Carolyn B. Coyne. "Unc93b Induces Apoptotic Cell Death and Is Cleaved by Host and Enteroviral Proteases." PloS one 10.10 (2015): e0141383. PMID:26509685
- 39.Chan, Zou, et al. "Design, Synthesis and Biological Evaluation of 1‐Benzyl‐1H‐pyrazole Derivatives as Receptor Interacting Protein 1 (RIP1) Kinase Inhibitors." Chemical biology & drug design (2015). PMID:26577270
- 40.Duan, Wenwen, et al. "Protein C‐terminal enzymatic labeling identifies novel caspase cleavages during the apoptosis of multiple myeloma cells induced by kinase inhibition." Proteomics (2015). PMID:26552366
- 41. Boyd-Tressler, Andrea, et al. "Chemotherapeutic Drugs Induce ATP Release via Caspase-gated Pannexin-1 Channels and a Caspase/Pannexin-1-Independent Mechanism." Journal of Biological Chemistry (2014): jbc-M114. PMID:25112874
- 42. El Zaoui, Ikram, Francine Behar-Cohen, and Alicia Torriglia. "Glucocorticoids exert direct toxicity on microvasculature: Analysis of cell death mechanisms." Toxicological Sciences (2014): kfu243. PMID:25447644
Quality Control & MSDS
- View current batch:
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
Related Biological Data
| Cell-permeable, irreversible pan-caspase inhibitor. Inhibits caspase processing and apoptosis induction in tumor cells in vitro (IC50 = 0.0015 - 5.8 mM). Active in vivo. | ||||||
| Targets | Caspase | |||||
| IC50 | 0.0015 - 5.8 mM | |||||
| Kinase experiment [1]: | |
|
Preventing the processing of CPP32 to its active form |
Z-VAD-FMK inhibits apoptosis by inhibiting the activation of CPP32, which presumably blocked the process by interfering directly with the processing of CPP32. |
| Cell experiment [2]: | |
|
Cell lines |
Human CD4+ (~ 97%) and CD8+ T (~ 98%) cells |
|
Preparation method |
The solubility of this compound in DMSO is >10 mM. General tips for obtaining a higher concentration: Please warm the tube at 37 °C for 10 minutes and/or shake it in the ultrasonic bath for a while.Stock solution can be stored below -20°C for several months. |
|
Reaction Conditions |
24 h |
|
Applications |
Z-VAD-FMK dose-dependently inhibited T cell proliferation mediated through the co-stimulation with anti-CD3 and anti-CD28. Z-IETD-FMK was less effective at 25 and 50 μM, but inhibited T cell proliferation at the 100 μM concentration. |
| Animal experiment [3]: | |
|
Animal models |
C57BL mice |
|
Dosage form |
1.25 mM, ear provocation |
|
Applications |
The right ear swelling degree, weight differences and thickness between two ears in the 1.25 mML Z-VAD-FMK group were significantly lower than those of the negative control (NC). The levels of INF-γ and IL-2 in the ear skin lesions, the mean intensity of BrdU in T lymphocytes, and the percent of activation markers-positive T lymphocytes were all lower than those of NC. |
|
Other notes |
Please test the solubility of all compounds indoor, and the actual solubility may slightly differ with the theoretical value. This is caused by an experimental system error and it is normal. |
|
References: [1]. Slee EA1, Zhu H, Chow SC et al. Benzyloxycarbonyl-Val-Ala-Asp (OMe) fluoromethylketone (Z-VAD.FMK) inhibits apoptosis by blocking the processing of CPP32. Biochem J. 1996 Apr 1;315 ( Pt 1):21-4. [2]. Lawrence CP1, Chow SC. Suppression of human T cell proliferation by the caspase inhibitors, z-VAD-FMK and z-IETD-FMK is independent of their caspase inhibition properties. Toxicol Appl Pharmacol. 2012 Nov 15;265(1):103-12. [3]. Li YY, Yan CL. Inhibition of elicitation of allergic contact dermatitis by topical use of Z-VAD-FMK, a broad caspase inhibitor: experiment in mice. Zhonghua Yi Xue Za Zhi. 2012 Jul 24;92(28):1992-6. | |
Z-VAD-FMK Dilution Calculator
Z-VAD-FMK Molarity Calculator
| Cas No. | 187389-52-2 | SDF | Download SDF |
| Synonyms | Benzyloxycarbonyl-Val-Ala-Asp(OMe)-fluoromethylketone,Z-Val-Ala-Asp(OMe)-FMK | ||
| Chemical Name | methyl (3S)-5-fluoro-3-[[(2S)-2-[[(2S)-3-methyl-2-(phenylmethoxycarbonylamino)butanoyl]amino]propanoyl]amino]-4-oxopentanoate | ||
| Canonical SMILES | CC(C)C(C(=O)NC(C)C(=O)NC(CC(=O)OC)C(=O)CF)NC(=O)OCC1=CC=CC=C1 | ||
| Formula | C22H30FN3O7 | M.Wt | 467.49 |
| Solubility | >23.4mg/mL in DMSO | Storage | Store at -20°C |
| General tips | For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months. | ||
| Shipping Condition | Evaluation sample solution : ship with blue ice All other available size: ship with RT , or blue ice upon request |
||
|
|||||||
|
|||||||
|
Abstract
The caspase inhibitor Z-VAD-FMK exhibits immunosuppressive and anti-proliferative activities in T cell without inhibiting the activity of caspases 8 and 3, where it inhibits NF-KB, the expression of CD25 and FasL-induced apoptosis.
Abstract
The effects of Z-VAD-FMK, a caspase inhibitor, on T lymphocytes and the elicitation of murine ACD were investigated.
Abstract
Intracerebroventricular administration of Z-VAD-FMK, a caspase inhibitor restricted by blood-brain barrier, to post-radiation rats resulted in reduced numbers of TUNEL-positive cells in the hypoglossal nucleus, suppressed expression and activation of caspases 3/8/9 and decrease appearance of cytochrome c in the cytosolic fraction.
Abstract
Z-VAD-FMK is a caspase inhibitor that inhibits mitochondria-related apoptotic effects induced by CIN.
Abstract
Early direct infusion of Z-VAD-FMK, a caspase inhibitor, into cochlear leads to accelerated hearing recovery and reduced hair cell loss in pigs suffering gunshot noise-induced trauma.
Z-VAD-FMK, an inhibitor of ICE-like proteases, inhibits apoptosis in THP.1 cells induced by diverse stimuli1 and Fas antigen-induced apoptosis in Jurkat T-cells2. It inhibits apoptosis by blocking the activation of proCPP32 into its active form, rather than by preventing the proteolytic action of CPP32 directly.
Z- VAD-FMK inhibits the formation of large kilobasepair fragments of DNA induced by diverse stimuli. Z-VAD-FMK had little or no effect on STS-induced necrotic cell death suggesting that the ICE-like protease activity was not involved in necrosis3.
Z-VAD-FMK almost completely inhibited the formation of large kilobasepair induced by all four stimuli. Similarly Z-VAD-FMK almost completely inhibited the enhanced formation of large kilobasepair fragments induced by thapsigargin or cycloheximide in the presence of TLCK, in good agreement with its ability to inhibit apoptosis induced by these treatments. These stimuli also induced internucleosomal cleavage of DNA, which was inhibited by Z-VAD-FMK. These results suggested that an ICE-like protease(s) acts at a stage prior to the formation of large kilobasepair fragments of DNA3.
References:
1. Darmon, A.J., Ehrman, N., Caputo, A., Fujinaga, J. and Bleackley, R.C. (1994) J. Biol. Chem. 269, 32043-32046.
2. Chow, S. C., Weis M., Kass, G. E. N., Holmstrom, T. H., Eriksson, J. E. and Orrenius S. (1995) FEBS Lett. 364, 134±138
3. H. Zhu et al./FEBS Letters 374 (1995) 303-308
